Efficacy of immune‐checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta‐analysis

BACKGROUND: Efficacy of immune checkpoint inhibitors (ICIs) in metastatic gastric/gastroesophageal junction (GEJ) adenocarcinoma is inconsistent. Whether the efficacy of ICIs is comparable across different subgroups remains unknown. METHODS: We identified randomized controlled trials (RCTs) that com...

Descripción completa

Detalles Bibliográficos
Autores principales: Kundel, Yulia, Sternschuss, Michal, Moore, Assaf, Perl, Gali, Brenner, Baruch, Goldvaser, Hadar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571828/
https://www.ncbi.nlm.nih.gov/pubmed/32869544
http://dx.doi.org/10.1002/cam4.3417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571828/
https://www.ncbi.nlm.nih.gov/pubmed/32869544
http://dx.doi.org/10.1002/cam4.3417

Ejemplares similares